Figure 1From: The maintenance of cisplatin- and paclitaxel-induced mechanical and cold allodynia is suppressed by cannabinoid CB2 receptor activation and independent of CXCR4 signaling in models of chemotherapy-induced peripheral neuropathy Chemical stuctures of compounds employed. Chemical structure of the cannabilactone CB2 agonist AM1710, the CXCR4 antagonist AMD3100, the CB2 receptor antagonist AM630 and the CB1 receptor antagonist AM251.Back to article page
